Skip to main content
CorMedix Inc. (CRMD)
NASDAQ: CRMD · Real-Time Price · USD
7.57
-0.25 (-3.20%)
At close: Apr 28, 2026, 4:00 PM EDT
7.93
+0.36 (4.76%)
Pre-market: Apr 29, 2026, 5:30 AM EDT

CorMedix Revenue

In the year 2025, CorMedix had annual revenue of $311.71M with 617.03% growth. CorMedix had revenue of $128.62M in the quarter ending December 31, 2025, with 312.10% growth.

Revenue (ttm)
$311.71M
Revenue Growth
+617.03%
P/S Ratio
1.90
Revenue / Employee
$1,631,984
Employees
191
Market Cap
593.70M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025311.71M268.24M617.03%
Dec 31, 202443.47M--
Dec 31, 2023---
Dec 31, 202265.41K-125.53K-65.74%
Dec 31, 2021190.94K-48.30K-20.19%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Rigel Pharmaceuticals 294.28M
Zevra Therapeutics 106.47M
Sutro Biopharma 102.48M
Prothena Corporation 9.68M
Aclaris Therapeutics 7.83M
Prime Medicine 4.63M
Ocugen 4.41M
Shattuck Labs 1.00M
Revenue Rankings

CRMD News

More News